Pro-inflammatory cytokine which is upregulated in the bleomycin model. Exogenous administration in vivo induced fibrosis, which was reduced by blockade of TGF-β. Upregulated in patients with IPF. Here, TGFB1 is linked to idiopathic pulmonary fibrosis.